Nanolive wants to congratulate the 2019 Nobel Prize in Physiology or Medicine which was assigned today to William G. Kaelin Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability. Their research identified the molecular machinery that regulates the activity of genes in response to varying levels of oxygen. The discoveries by this year’s Nobel Laureates revealed the mechanism for one of life’s most essential adaptive processes.

They established the basis for our understanding of how oxygen levels affect cellular metabolism and physiological function.

Their discoveries have also paved the way for promising new strategies to fight anemia, cancer and many other diseases.

Please, find the official press release at this link: https://www.nobelprize.org/prizes/medicine/2019/press-release/.

Read our latest news

Label-free assessment of immunotherapies for liquid tumors

Jul 31, 2026 | News

From activation to target engagement and killing, Nanolive’s revolutionary technology enables the identification of the most effective therapeutic candidates for liquid tumors using live, label-free and advanced automated analysis of effector cell activity and function. Discover the case study data.

Simplifying drug delivery assessment: Industry perspectives

Jul 8, 2026 | News

Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.

Webinar – Investigating nanoparticle delivery with label-free live cell imaging

Jun 18, 2026 | Immuno-oncology, News

Watch our latest webinar, where Elizabeth Nelson shares research performed at the MIT Koch Institute for Integrative Cancer Research, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles…

More news